Merck Animal Health Announces New Naming for its Vaccine Portfolio

Cattle Vaccines Will Lead With the Name, Bovilis®

Merck Animal Health has announced new naming for its cattle vaccine portfolio; one of the largest and most comprehensive vaccine portfolios in the industry. The goal of the new naming and packaging is to make it easier for customers to recognize the company’s vaccines and to identify specific formulations.

“All Merck Animal Health cattle vaccines will lead with Bovilis® followed by the current product name, such as Bovilis® Vista®, Bovilis® Vision® or Bovilis® Guardian,” says Scott Nordstrom, D.V.M., director of livestock innovation and discovery, Merck Animal Health. “In addition, all vaccine packaging will share a new, consistent design and color coding to make it easier for customers to identify the vaccine formulation needed.”

Veterinarians and producers will start seeing the new packaging in the coming weeks, but the switch of the entire portfolio will not happen overnight.

“The vaccines that veterinarians and producers rely on have not changed – only the branding,” explains Nordstrom. “Customers can confidently use vaccine in the previous packaging through the expiration date.”

New vaccines will be introduced under the Bovilis name. This includes the latest vaccine, Bovilis® Nasalgen® 3-PMH, the only intranasal BRD vaccine against viral and bacterial pneumonia.

“Our commitment to improve the health and well-being of cattle has been the driver to developing new vaccines,” says Nordstrom. “Merck Animal Health has introduced more vaccines in the last three years than any other animal health company.”